Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 3 boards, counting each seat separately. Longest: Bolt Biotherapeutics Inc., 3 years.
Bolt Biotherapeutics Inc.
Director
Pacira BioSciences Inc.
Director · Chief Executive Officer
Bausch Health Companies Inc.
Director
Chief executive roles
Pacira BioSciences Inc.
· Chief Executive Officer
Since January 2024
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 22, 2026 | Bausch Health Companies Inc. | Grant or award | +45,871 | — | — |
| May 19, 2026 | Bausch Health Companies Inc. | Open-market sale | −24,456 | $5.43 | $132,796 |
| Feb 11, 2026 | Pacira BioSciences Inc. | Grant or award | +261,818 | — | — |
| Jan 30, 2026 | Pacira BioSciences Inc. | Shares withheld for tax | −41,488 | $20.54 | $852,164 |
| Jan 2, 2026 | Pacira BioSciences Inc. | Shares withheld for tax | −9,272 | $24.46 | $226,793 |
| Aug 21, 2025 | Bausch Health Companies Inc. | Open-market sale | −15,912 | $7.66 | $121,886 |
| May 16, 2025 | Bausch Health Companies Inc. | Grant or award | +54,347 | — | — |
| Feb 1, 2025 | Pacira BioSciences Inc. | Grant or award | +350,000 | — | — |
| Jan 2, 2025 | Pacira BioSciences Inc. | Shares withheld for tax | −9,375 | $18.33 | $171,844 |
| Aug 12, 2024 | Pacira BioSciences Inc. | Open-market purchase | +8,264 | $12.10 | $99,994 |
| May 17, 2024 | Bausch Health Companies Inc. | Grant or award | +35,360 | — | — |
| Jan 2, 2024 | Pacira BioSciences Inc. | Grant or award | +99,520 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.